• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES

    4/20/26 2:50:00 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care
    Get the next $VTAK alert in real time by email

    Major Carriers Accelerate Route Cuts as Economics Break Down, Creating Multi-Billion-Dollar Opportunity in Regional Air Mobility

    Flyte Expands Focus on High-Frequency Short-Haul Routes to Capture Surging Demand as Industry Economics Continue to Shift

    FORT MILL, S.C., April 20, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced it is accelerating expansion in short-haul markets as major global airlines rapidly retreat from regional routes amid rising fuel costs, operational constraints, and shifting route economics. This pullback reflects a structural shift, creating a sustained opportunity for high-frequency regional air mobility.

    Across the industry, carriers are cutting short-distance routes and reallocating aircraft toward longer-haul, higher-margin markets. What began as selective reductions has evolved into a broader network realignment that disproportionately impacts short-haul and secondary-city routes.

    Rising jet fuel costs and supply pressures have forced airlines to reevaluate route profitability, particularly where short-distance economics are most sensitive. As a result, regional routes are being cut or eliminated, reinforcing a sustained capacity shift away from short-haul markets.

    This dynamic is creating a widening gap in critical travel corridors, especially across the Northeast, where demand for high-frequency, point-to-point travel remains strong despite declining airline service.

    Flyte is positioned directly in the center of this market dislocation.

    "We believe the industry is not temporarily adjusting, it is structurally pulling away from short-haul flying," said Marc Sellouk, CEO of Flyte. "That capacity does not come back easily. As airlines move up-market and focus on longer routes, a meaningful portion of regional connectivity is being left behind. That is exactly where Flyte operates."

    A STRUCTURAL SHIFT DRIVING REGIONAL IMBALANCE

    Airlines are increasingly deprioritizing short-haul routes for four converging reasons:

    • Elevated and volatile fuel costs that disproportionately erode short-distance economics
    • High fixed costs tied to takeoffs, landings, and airport operations
    • Air traffic control and infrastructure constraints at major hubs
    • Strategic redeployment of aircraft to long-haul and premium routes
    • The downstream effects for travelers are already visible:
    • Flight frequency is declining
    • Direct routes are disappearing
    • Travel friction and delays are increasing

    Despite these reductions, demand for short-distance travel remains resilient, particularly among business and high-income travelers who cannot absorb lost connectivity.

    FLYTE IS BUILT FOR THE GAP AIRLINES ARE LEAVING BEHIND

    Flyte's model is directly aligned with the segments being vacated by commercial airlines. Operating under FAA Part 135 certification, Flyte utilizes the Cirrus Vision Jet to deliver high-frequency, short-haul service in markets where traditional airline capacity is limited and declining.

    As airline networks continue to evolve, demand is expected to shift toward point-to-point solutions that offer more efficient aircraft utilization on shorter routes, reduced dependence on congested hub infrastructure, and greater flexibility in scheduling and frequency. Flyte addresses these needs with right-sized aircraft that consume materially less fuel per trip than traditional commercial jets, enabling efficient regional operations.

    Core advantages:

    • Point-to-Point Network - Direct routes that eliminate connections and bypass congestion

    • Regional Airport Access - Closer proximity to end destinations and faster total travel time

    • Right-Sized Economics - Optimized cost structure for short-haul missions

    • Flexible, High-Frequency Capacity - Designed for markets with demand but declining airline supply

    SHIFTING TRAVEL ECONOMICS FAVOR REGIONAL ALTERNATIVES

    As airlines increase pricing to offset higher operating costs, the gap between premium commercial travel and regional shuttle alternatives may narrow in select markets. Flyte's model is engineered to deliver competitive per-seat economics in shared formats, direct routing without connection delays, and meaningful time savings for business and premium leisure travelers, positioning regional air mobility as an increasingly compelling option where airline service is being reduced.

    SCALABLE PLATFORM, ACTIVE OPERATIONS

    Flyte operates an established FAA-certified platform with active, revenue-generating operations, real-time demand visibility, and capital-efficient fleet expansion capability. Through full ownership of Flyte, VTAK retains the flexibility to scale into markets where declining airline connectivity is creating incremental demand.

    POSITIONED FOR CONTINUED TAILWINDS

    As airlines continue optimizing for profitability, management expects the reduction in short-haul capacity to persist and potentially accelerate. Flyte anticipates continued declines in regional airline service, increasing pricing power in underserved markets, and growing adoption of alternative air travel solutions.

    "We are not competing where airlines are strongest," added Sellouk. "We are building where they are exiting. That creates a powerful tailwind for our model."

    About Flyte

    Flyte is a technology-enabled regional air mobility company operating a growing fleet of Cirrus Vision Jets. Focused on short-haul markets, Flyte provides a faster and more efficient alternative to traditional private charter travel.

    Flight operations are conducted through Flyte's wholly owned subsidiary, Ponderosa Air, LLC, an FAA-certified Part 135 air carrier. With active operations and ongoing fleet expansion, Flyte is building a scalable aviation platform designed to serve underserved regional markets.

    For more information, visit www.flyte.travel

    About Catheter Precision

    Catheter Precision is an innovative U.S.-based medical device company developing advanced solutions to improve the treatment of cardiac arrhythmias. The Company focuses on bringing new technologies to market through physician collaboration and continuous product innovation.

    Cautionary Note Regarding Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements regarding future plans, expectations, and projections, are forward-looking and subject to risks and uncertainties that could cause actual results to differ materially. Forward-looking statements contained in this press release include, but are not limited to, statements regarding the following: our belief the industry is not temporarily adjusting but is structurally pulling away from short-haul flying, our expectation that demand will shift toward point-to-point solutions that offer more efficient aircraft utilization on shorter routes and reduced dependence on congested hub infrastructure, and greater flexibility in scheduling and frequency and management's expectations the reduction in short-haul capacity to persist and potentially accelerate.  The Company's expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks and changes in circumstances, including but not limited to risks and uncertainties included under the caption "Risk Factors" in the Company's filings with the Securities and Exchange Commission, including its most recent Forms 10-K and 10-Q. The Company undertakes no obligation to update any forward-looking statements except as required by law.

    Contacts

    Investor Relations

    973-691-2000

    [email protected]

    Media Relations

    [email protected]



    Primary Logo

    Get the next $VTAK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VTAK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VTAK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES

    Major Carriers Accelerate Route Cuts as Economics Break Down, Creating Multi-Billion-Dollar Opportunity in Regional Air Mobility Flyte Expands Focus on High-Frequency Short-Haul Routes to Capture Surging Demand as Industry Economics Continue to Shift FORT MILL, S.C., April 20, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced it is accelerating expansion in short-haul markets as major global airlines rapidly retreat from regional routes amid rising fuel costs, operational constraints, and shifting route economics. This pullback reflects a structural shift, creating a sustained opportunity for high-frequency regio

    4/20/26 2:50:00 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval

    Transaction Delivers Fully Consolidated, Revenue-Generating, Aviation Business with Accelerating Growth Positions VTAK for Scalable Expansion in Regional Air Mobility Ahead of eVTOL Commercialization FORT MILL, S.C., April 16, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) today announced it received shareholder approval on April 15th of the definitive agreement to acquire Fly Flyte, Inc. ("Flyte") executed on March 9. The March 9th transaction establishes Flyte as a wholly owned operating subsidiary, delivering immediate consolidation of revenue, assets, and operating performance into VTAK. Full Ownership, Consolidated Revenue and Immediate Operating Exposure Flyte ope

    4/16/26 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Catheter Precision Announces Accepted Publication in Leading European Medical Journal

    FORT MILL, S.C., April 13, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company") today announced that the results of a recently concluded VIVO study have been accepted in EP Europace, the leading European electrophysiology journal. The EP Europace journal provides an avenue of communication for top-quality European and international original, scientific work and reviews in the fields of arrhythmias, pacing and cellular electrophysiology. The journal offers readers a collection of contemporary, original, peer-reviewed papers, invited papers and editorial comments, together with book reviews and correspondence. The accepted manuscript titled "Accuracy of a

    4/13/26 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $VTAK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Jenkins David A

    4 - Catheter Precision, Inc. (0001716621) (Issuer)

    3/30/26 5:58:17 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Anderson Philip J

    4 - Catheter Precision, Inc. (0001716621) (Issuer)

    3/30/26 5:58:15 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Arno Andrew

    4 - Catheter Precision, Inc. (0001716621) (Issuer)

    3/30/26 5:58:11 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $VTAK
    SEC Filings

    View All

    Catheter Precision Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Catheter Precision, Inc. (0001716621) (Filer)

    4/15/26 4:16:35 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Catheter Precision Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Catheter Precision, Inc. (0001716621) (Filer)

    3/31/26 4:55:13 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Catheter Precision Inc.

    10-K - Catheter Precision, Inc. (0001716621) (Filer)

    3/31/26 11:07:34 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $VTAK
    Leadership Updates

    Live Leadership Updates

    View All

    Catheter Precision, Inc. Announces New Chief Financial Officer

    FORT MILL, SC / ACCESSWIRE / January 7, 2025 / Catheter Precision, Inc. (NYSE:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has brought on board Philip Anderson, to take on the position of Chief Financial Officer. Margrit Thomassen, who has been our Interim Chief Financial Officer, will continue with the company in the role of Controller.David Jenkins, CEO of Catheter Precision, commented on the hire, "After some time of searching for the right fit, we are happy to have concluded our search with Phil Anderson joining the team. His background includes executive management across a variety of industries, managing hedge fund

    1/7/25 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Sequire Investor Summit in Puerto Rico

    FORT MILL, SC / ACCESSWIRE / January 22, 2024 / Catheter Precision, Inc. (NYSE:VTAK), (the Company) a pioneering U.S. based medical device company committed to enhancing the well-being of patients with cardiac arrhythmias, is pleased to declare its participation in the forthcoming Sequire Investor Summit 2024. The eagerly awaited event, slated for January 23-25, 2024, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico, is poised to provide a spectrum of compelling opportunities for funds, companies, and investors.Puerto Rico has become a hub for family offices, funds, and affluent investors, thanks to its advantageous tax benefits. It stands out as one of the rare locations globally wh

    1/22/24 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $VTAK
    Financials

    Live finance-specific insights

    View All

    Catheter Precision Reports 2025 Results and Updates on Strategic Expansion

    Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year Acquisition of Flyte and Strengthened Capital Position Unlock Multi-Segment Growth Strategy with Multiple Near-Term Catalysts FORT MILL, S.C., March 31, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the fourth quarter and full year ended December 31, 2025 as well as certain other business updates. 2025: Execution Across Clin

    3/31/26 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    CRTD (Creatd Inc.) Sells Remaining 80% of Fly Flyte to NYSE-Listed VTAK (Catheter Precision Inc.), Securing Significant Cash and Equity Position

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. ("Flyte"), to Catheter Precision, Inc. (NYSE:VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd's balance sheet. The sale is consistent with Creatd's strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. The transaction positions Cr

    3/10/26 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

    Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) announced that Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd's strategy of nurtu

    2/17/26 2:17:42 PM ET
    $CRTD
    $VTAK
    Publishing
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    $VTAK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Catheter Precision Inc.

    SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)

    11/14/24 5:12:56 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Catheter Precision Inc.

    SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)

    11/13/24 11:14:58 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by Catheter Precision Inc.

    SC 13D/A - Catheter Precision, Inc. (0001716621) (Subject)

    10/30/24 5:26:20 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care